Press Release Details

Cerus to Present at Cowen and Company 28th Annual Health Care Conference

March, 10 2008

CONCORD, Calif.--(BUSINESS WIRE)--March 10, 2008--Cerus Corporation (NASDAQ:CERS) announced today that company management will present at the Cowen and Company 28th Annual Health Care Conference in Boston, MA. Cerus will present at 4:45 p.m. EST on Monday, March 17, 2008 at the Boston Marriott Copley Place. The presentation will be followed by a 35-minute breakout session starting at 5:30 p.m. To access the live webcast, please log on to the company's website at www.cerus.com. An archived presentation will be available on the website until April 17, 2008.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe and the Middle East. The company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

CONTACT: Cerus Corporation
William J. Dawson
Vice President, Finance & CFO
925-288-6053
or
Vida Communication (On behalf of CERUS)
Stephanie Diaz
415-675-7401

SOURCE: Cerus Corporation

    Global Headquarters

  • 1220 Concord Avenue
  • Concord, CA US 94520
  • +1 925.288.6000

    European Headquarters

  • Stationsstraat 79-D
  • 3811 MH Amersfoort, Netherlands
  • +31 (0) 33 49 60 600